430 related articles for article (PubMed ID: 21512182)
1. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR).
Wang Y; Liao X; Zhao X; Wang DZ; Wang C; Nguyen-Huynh MN; Zhou Y; Liu L; Wang X; Liu G; Li H; Wang Y;
Stroke; 2011 Jun; 42(6):1658-64. PubMed ID: 21512182
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist Impact on Ischemic Stroke Care in the Emergency Department.
Gosser RA; Arndt RF; Schaafsma K; Dang CH
J Emerg Med; 2016 Jan; 50(1):187-93. PubMed ID: 26412104
[TBL] [Abstract][Full Text] [Related]
3. Use of Emergency Medical Services and Timely Treatment Among Ischemic Stroke.
Gu HQ; Rao ZZ; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Wang CY; Liu C; Li H; Li ZX; Xiao RP; Wang YJ;
Stroke; 2019 Apr; 50(4):1013-1016. PubMed ID: 30841820
[TBL] [Abstract][Full Text] [Related]
4. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
[TBL] [Abstract][Full Text] [Related]
6. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
[TBL] [Abstract][Full Text] [Related]
7. 10-year Temporal Trends of Intravenous Thrombolysis in Acute Ischemic Stroke: Analysis of the China National Stroke Registry I-Ⅲ.
Jia W; Jiang Y; Ma R; Huang X; Gu H; Meng X; Li H; Zhao X; Wang Y; Wang Y; Li Z; Wang C
J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107431. PubMed ID: 37951082
[TBL] [Abstract][Full Text] [Related]
8. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
[TBL] [Abstract][Full Text] [Related]
9. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time.
Sauser K; Levine DA; Nickles AV; Reeves MJ
JAMA Neurol; 2014 Sep; 71(9):1155-61. PubMed ID: 25023407
[TBL] [Abstract][Full Text] [Related]
10. Posterior circulation stroke is associated with prolonged door-to-needle time.
Sarraj A; Medrek S; Albright K; Martin-Schild S; Bibars W; Vahidy F; Grotta JC; Savitz SI
Int J Stroke; 2015 Jul; 10(5):672-8. PubMed ID: 23521891
[TBL] [Abstract][Full Text] [Related]
11. ACT-FAST: a quality improvement project to increase the percentage of acute stroke patients receiving intravenous thrombolysis within 60 minutes of arrival at the emergency department.
Chiu LQ; Quek DYJ; Salihan RB; Ng WM; Othman RB; Lee CH; Oh DCT
Singapore Med J; 2021 Sep; 62(9):476-481. PubMed ID: 32227791
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the implementation of a 24-hr stroke thrombolysis emergency treatment for patients with acute ischaemic stroke.
Zhao J; Li X; Liang Y; Zhao L; Zhang X; Liu Y
J Clin Nurs; 2018 May; 27(9-10):2161-2167. PubMed ID: 29345016
[TBL] [Abstract][Full Text] [Related]
13. Improving timely treatment with a stroke emergency map: The case of northern China.
Zhang T; Zhang X; Sun H; Zhou F; Lin S; Sang H; Zheng N; Zhao Z; Shi J; Li W
Brain Behav; 2020 Aug; 10(8):e01743. PubMed ID: 32652889
[TBL] [Abstract][Full Text] [Related]
14. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.
Kent DM; Price LL; Ringleb P; Hill MD; Selker HP
Stroke; 2005 Jan; 36(1):62-5. PubMed ID: 15569865
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in China.
Wang HY; Gu HQ; Zhou Q; Jiang YY; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Meng X; Li H; Liu C; Li ZX; Wang YJ; Jiang Y
BMJ Open; 2022 Jun; 12(6):e055055. PubMed ID: 35750455
[TBL] [Abstract][Full Text] [Related]
16. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
[TBL] [Abstract][Full Text] [Related]
17. Stroke thrombolysis: having more time translates into delayed therapy: data from the Austrian Stroke Unit Registry.
Ferrari J; Knoflach M; Kiechl S; Willeit J; Matosevic B; Seyfang L; Lang W;
Stroke; 2010 Sep; 41(9):2001-4. PubMed ID: 20689080
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of the Cincinnati Prehospital Stroke Scale for identifying thrombolytic candidates in acute ischemic stroke.
You JS; Chung SP; Chung HS; Lee HS; Park JW; Kim HJ; Lee SH; Park I; Lee HS
Am J Emerg Med; 2013 Dec; 31(12):1699-702. PubMed ID: 24055479
[TBL] [Abstract][Full Text] [Related]
19. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke.
Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
JAMA; 2020 Jun; 323(21):2170-2184. PubMed ID: 32484532
[TBL] [Abstract][Full Text] [Related]
20. Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials.
Gumbinger C; Reuter B; Stock C; Sauer T; Wiethölter H; Bruder I; Rode S; Kern R; Ringleb P; Hennerici MG; Hacke W;
BMJ; 2014 May; 348():g3429. PubMed ID: 24879819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
